Published in J Allergy Clin Immunol on February 01, 2003
Rhinosinusitis and asthma: the missing link. Curr Opin Pulm Med (2009) 1.04
Comparison of orally exhaled nitric oxide in allergic versus nonallergic rhinitis. Am J Rhinol Allergy (2012) 0.83
The role of inhaled and/or nasal corticosteroids on the bronchodilator response. Korean J Pediatr (2010) 0.75
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2007) 5.51
Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J (2006) 3.27
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2003) 2.43
Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest (2010) 2.29
Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med (2014) 2.00
A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada. Environ Health Perspect (2009) 1.77
Unsuspected loss of lung elastic recoil in chronic persistent asthma. Chest (2002) 1.72
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med (2006) 1.71
Reference values of pulmonary function tests for Canadian Caucasians. Can Respir J (2004) 1.58
Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study. Chest (2010) 1.49
The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest (2006) 1.38
Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24
Mounier-Kuhn syndrome: a rare cause of severe bronchial dilatation with normal pulmonary function test: a case report. Respir Med (2007) 1.23
Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. Respir Med (2013) 1.19
Regulation of epithelium-specific Ets-like factors ESE-1 and ESE-3 in airway epithelial cells: potential roles in airway inflammation. Cell Res (2008) 1.13
Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest (2006) 1.11
What do we know about asthma triggers? a review of the literature. J Asthma (2012) 1.06
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04
Variations and gaps in management of acute asthma in Ontario emergency departments. Chest (2008) 0.97
The coming of age of asthma guidelines. Lancet (2008) 0.96
Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med (2002) 0.95
Simplified detection of dynamic hyperinflation. Chest (2004) 0.95
Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study. PLoS One (2013) 0.94
Diffuse panbronchiolitis in a Caucasian man in Canada. Can Respir J (2003) 0.89
Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America. World Allergy Organ J (2013) 0.89
Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.89
Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89
Physiologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med (2008) 0.88
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology (2012) 0.88
Risk factors for near-fatal asthma. Chest (2004) 0.88
Brazilian version of airways questionnaire 20: a reproducibility study and correlations in patients with COPD. Respir Med (2004) 0.87
Profile of eicosanoids in breath condensate in asthma and COPD. J Breath Res (2012) 0.87
Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest (2003) 0.86
Women and asthma: lessons from a gender analysis of the asthma in Canada survey. J Asthma (2006) 0.85
Omalizumab for asthma: pharmacology and clinical profile. Expert Rev Respir Med (2009) 0.84
Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries. J Asthma (2013) 0.84
A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate. Pharmacogenet Genomics (2007) 0.84
Hot tub lung mimicking classic acute and chronic hypersensitivity pneumonitis: two case reports. Can Respir J (2007) 0.84
Alveolar and airway sites of nitric oxide inflammation in treated asthma. Am J Respir Crit Care Med (2004) 0.84
Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor. Eur Respir J (2012) 0.83
Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? Treat Respir Med (2005) 0.83
Influence of current or former smoking on asthma management and control. Can Respir J (2008) 0.83
Economic issues in the use of office spirometry for lung health assessment. Can Respir J (2003) 0.82
Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ (2012) 0.82
The value of early diagnosis for effective management of chronic obstructive pulmonary disease. J Fam Pract (2007) 0.82
The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med (2008) 0.82
Dynamic airway evaluation with volume CT: initial experience. Can Assoc Radiol J (2010) 0.82
Caries prevalence in patients with cerebral palsy and the burden of caring for them. Spec Care Dentist (2010) 0.81
Lung elastic recoil in acute and chronic asthma. Curr Opin Pulm Med (2002) 0.81
A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha. Pharmacogenetics (2003) 0.81
Evaluation of a questionnaire to assess compliance with anti-asthma medications. J Asthma (2004) 0.81
Tiotropium induced bronchodilation and protection from dynamic hyperinflation is independent of extent of emphysema in COPD. Pulm Pharmacol Ther (2009) 0.80
Parent-reported symptoms may not be adequate to define asthma control in children. Pediatr Pulmonol (2007) 0.80
Review of exhaled nitric oxide in chronic obstructive pulmonary disease. J Breath Res (2012) 0.80
Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction. Int J Gen Med (2010) 0.79
Effect of spastic cerebral palsy on jaw-closing muscles during clenching. Spec Care Dentist (2010) 0.79
Tiotropium and simplified detection of dynamic hyperinflation. Chest (2007) 0.79
Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario. Can Respir J (2011) 0.78
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study. BMC Clin Pharmacol (2010) 0.78
Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial. Braz J Infect Dis (2008) 0.78
Glutamate and synaptic plasticity systems and smoking behavior: results from a genetic association study. PLoS One (2012) 0.77
Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma. Respir Med (2009) 0.76
Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients. Can Respir J (2008) 0.76
SMART isn't. J Allergy Clin Immunol (2010) 0.76
Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: a comparison of predictive equations and altitude simulation. Can Respir J (2009) 0.75
A step forward in COPD management: reading between the lines. Chest (2012) 0.75
Salivary osmolality in individuals with cerebral palsy. Arch Oral Biol (2010) 0.75
Seretide: a pharmacoeconomic analysis. J Med Econ (2008) 0.75
[Discriminative properties and validity of a health status questionnaire in obstructive airway disease patients: the Airway Questionnaire 20]. Arch Bronconeumol (2007) 0.75
Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management. COPD (2015) 0.75
A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study. J Glaucoma (2017) 0.75
Salivary osmolality and hydration status in children with cerebral palsy. J Oral Pathol Med (2011) 0.75
Asthma controller delay and recurrence risk after an emergency department visit or hospitalization. Respir Med (2012) 0.75
Lack of protective effect of tiotropium vs induced dynamic hyperinflation in moderate COPD. Respir Med (2010) 0.75
Alveolar exhaled nitric oxide is elevated in hereditary hemorrhagic telangiectasia. Lung (2008) 0.75